Literature DB >> 31287402

Predictive factors and prognosis of macrophage activation syndrome associated with adult-onset Still's disease.

Xiao-Pei Yang1, Man Wang1, Tian-Fang Li1, Wei Li1, Lei Zhang1, Sheng-Yun Liu2.   

Abstract

OBJECTIVES: To summarise the clinical data of adult-onset Still's disease (AOSD) patients and analyse their clinical manifestations, predictors for the formation and prognosis of macrophage activation syndrome (MAS).
METHODS: A retrospective analysis was performed on the clinical data of 182 AOSD hospitalised patients from the Department of Rheumatology of the First Affiliated Hospital of Zhengzhou University, China from January 2012 to August 2018, including 11 patients with pathogenesis of MAS.
RESULTS: Compared with the patients without MAS, the patients with MAS had a higher incidence of splenomegaly and pericarditis at the initial diagnosis of AOSD. The number of platelets (PLT) and the concentration of fibrinogen (FIB), D-Dimer and ferritin were significantly higher in AOSD-MAS patients. Multivariate regression analysis showed that splenomegaly (OR: 5.748, 95% CI: 1.378-23.984, p=0.016), pericarditis (OR: 6.492, 95% CI: 1.43-29.461, p=0.015), and ferritin >2000 μg/L (OR: 4.715, 95% CI: 1.12-19.86, p=0.035) were risk factors for MAS. Survival analysis indicated that the mortality of AOSD-MAS patients was significantly higher than patients without MAS.
CONCLUSIONS: Splenomegaly, pericarditis and elevated ferritin concentration are risk factors for MAS formation in AOSD patients. MAS resulted in a significant decrease in the survival rate of the AOSD patients.

Entities:  

Year:  2019        PMID: 31287402

Source DB:  PubMed          Journal:  Clin Exp Rheumatol        ISSN: 0392-856X            Impact factor:   4.473


  4 in total

Review 1.  Progress in Biological Therapies for Adult-Onset Still's Disease.

Authors:  Paola Galozzi; Sara Bindoli; Andrea Doria; Paolo Sfriso
Journal:  Biologics       Date:  2022-04-21

2.  Detection and Prediction of Macrophage Activation Syndrome in Still's Disease.

Authors:  Clément Javaux; Thomas El-Jammal; Pierre-Antoine Neau; Nicolas Fournier; Mathieu Gerfaud-Valentin; Laurent Perard; Marine Fouillet-Desjonqueres; Julie Le Scanff; Emmanuelle Vignot; Stéphane Durupt; Arnaud Hot; Alexandre Belot; Isabelle Durieu; Thomas Henry; Pascal Sève; Yvan Jamilloux
Journal:  J Clin Med       Date:  2021-12-31       Impact factor: 4.241

3.  Elevated Serum D-Dimer May Reflect the Presence of Gut Inflammation in Spondyloarthritis.

Authors:  Jiaqi Feng; Jia Li; Yixuan Li; Yuyang Jin; Fang Du; Xiaoxiang Chen
Journal:  Front Med (Lausanne)       Date:  2022-01-21

4.  Associated factors with poor treatment response to initial glucocorticoid therapy in patients with adult-onset Still's disease.

Authors:  Fumiaki Kondo; Takahiko Sugihara; Natsuka Umezawa; Hisanori Hasegawa; Tadashi Hosoya; Naoki Kimura; Masaaki Mori; Shinsuke Yasuda
Journal:  Arthritis Res Ther       Date:  2022-04-29       Impact factor: 5.606

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.